Citius Oncology, Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

1.060

-0.040 (-3.64%)

Jan 30, 2026, 4:00 PM EST - Market closed

Citius Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Market Capitalization	94	170	99	96	-
Market Cap Growth	13.72%	71.05%	2.93%	-	-
Enterprise Value	93	173	-	-	-
Last Close Price	1.06	2.03	1.39	10.77	-
PB Ratio	1.97	3.78	2.15	3.77	-
P/TBV Ratio	2.09	3.78	2.15	3.77	-
P/OCF Ratio	-	-	784.41	-	-
Debt / Equity Ratio	0.09	0.09	0.08	-	-
Quick Ratio	0.08	0.08	0	-	-
Current Ratio	0.56	0.56	0.34	0.37	0.46
Return on Equity (ROE)	-54.42%	-54.42%	-59.01%	-41.09%	-
Return on Assets (ROA)	-15.87%	-15.87%	-19.47%	-16.76%	-
Return on Capital Employed (ROCE)	-45.70%	-45.70%	-39.80%	-45.40%	-26.40%
Earnings Yield	-26.46%	-14.61%	-21.34%	-13.19%	-
Buyback Yield / Dilution	-7.66%	-7.66%	-0.82%	-100.00%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q